PepCalcs
    Back to Library

    Vesilute

    Research Use OnlyPreclinical / limited Russian clinical research. Not FDA approved.

    Vesilute

    Description

    A bioregulator peptide for bladder and prostate health. Supports urinary function and prostate tissue regeneration.

    Dose:2 mg
    Frequency:30 days in a row, 2-3x per year
    Administration Method: SQ
    CategoryBioregulator
    Half-LifeVery short (minutes).

    Overview

    Vesilute (also called Vesilut, ED dipeptide) is part of the Khavinson family of short peptide bioregulators. Research focuses on urinary tract and prostate function, with proposed benefits for bladder regulation, microcirculation, and prostate tissue health.

    Mechanism of Action

    Synthetic dipeptide (Glu-Asp / ED) Khavinson bioregulator proposed to interact with ATTT DNA motifs and modulate gene expression in bladder and prostate tissues.

    Benefits

    • •Bladder health
    • •Prostate health
    • •Urinary support
    • •Tissue regeneration

    Reported Side Effects

    • •Limited human safety data
    • •Possible injection site reactions

    Safety Notes

    Independent clinical evidence is limited. Research use only.

    Scientific References

    Related Bioregulator Peptides